Weight loss drugs

 https://www.nbcnews.com/health/health-news/weight-loss-drug-affordability-rcna60422

from the article:

A phase 3 clinical trial found a high dose of tirzepatide helped patients lose 22.5% of their body weight on average, or about 52 pounds, better than any medication currently on the market. Most patients in the trial had a body mass index, or BMI, of 30 or higher. In trials, Wegovy and Saxenda reduced body weight by around 15% and around 5%, respectively. 

Are weight loss drugs covered by insurance?

At lower doses, all three of the drugs are already approved to treat diabetes.

• Tirzepatide is sold under the name Mounjaro for diabetes.
• Semaglutide, when marketed for weight loss, is sold at a higher dose and called Wegovy; at a lower dose, it’s marketed for diabetes and sold as Ozempic.
• Similarly, a higher dose of the drug liraglutide is sold under the name Saxenda for weight loss, and at a lower dose, it’s sold as Victoza, for diabetes.